Search - tctmd.com

Displaying 541 - 560 of 671

Presentation TCT 2013

Profile and Outcome of Very Late Bare Metal Stent Thrombosis Treated With Percutaneous Coronary Intervention

Presenter: Ivan Gomez Blazquez, Emiliano Fdez-Obanza, Victor A. Jimenez Diaz, Jorge Sep?lveda, Antonio De Miguel Castro, Guillermo Bastos Fern?ndez, Josu? Ponce Bustillo, Alberto Ortiz Saez, Jose A. Baz Alonso, Andres I?iguez

January 31, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Daily News

EES Outperform First-Generation DES in Treatment of CTOs

L.A. McKeown

December 27, 2012

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Jason Kahn

December 05, 2012

News Daily News

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

November 20, 2012

News Daily News

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Caitlin E. Cox

November 15, 2012

News Conference News AHA 2012

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Jason Kahn

November 04, 2012

News Conference News TCT 2012

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

November 02, 2012

Presentation TCT 2012

Update: Everything You Need to Know About Stent Thrombosis Management in 2012

Presenter: Alaide Chieffo

October 26, 2012

Presentation TCT 2012

Late Bare Metal Stent Thrombosis in the Light of OCT: Management Options?

Presenter: Pasi Karjalainen

October 24, 2012

Presentation TCT 2012

Case Presentation (with Discussion): Recurrent DES Thrombosis

Presenter: Jose de la Torre Hernandez

October 22, 2012

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Jason Kahn

October 05, 2012

News Daily News

Stent Fractures Persist Among Newer-Generation Devices

Jason Kahn

October 02, 2012

News Daily News

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

September 19, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Daily News

SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent

Yael L. Maxwell

September 07, 2012

News Conference News ESC 2012

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

August 27, 2012

News Daily News

SORT OUT III: Riesgo más alto de trombosis del stent muy tardía con Cypher en comparación con Endeavor

L.A. McKeown

August 23, 2012

Advertisement

Profile and Outcome of Very Late Bare Metal Stent Thrombosis Treated With Percutaneous Coronary Intervention

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

EES Outperform First-Generation DES in Treatment of CTOs

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

Update: Everything You Need to Know About Stent Thrombosis Management in 2012

Late Bare Metal Stent Thrombosis in the Light of OCT: Management Options?

Case Presentation (with Discussion): Recurrent DES Thrombosis

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Stent Fractures Persist Among Newer-Generation Devices

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

SORT OUT III: Riesgo más alto de trombosis del stent muy tardía con Cypher en comparación con Endeavor

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content